New Recommendations to Eliminate Racial Bias in Blood Cancer Trials by Colleen Fleiss on February 18, 2021 at 11:12 PM
New recommendations are being designed to address the under-representation of African Americans in clinical trials for multiple myeloma (MM), a blood cancer that is twice as deadly in this demographic as in whites, said researchers from Dana-Farber Cancer Institute, the U.S. Food and Drug Administration (FDA) and the American Association for Cancer Research (AACR).
Researchers from Dana-Farber Cancer Institute, the U.S. Food and Drug Administration (FDA) and the American Association for Cancer Research (AACR) are releasing recommendations designed to address the under-representation of African Americans in clinical trials for multiple myeloma (MM), a blood cancer that is twice as deadly in this demographic as in whites.
Immune Cell in Blood may Increase Severe COVID-19 Risk by Angela Mohan on January 29, 2021 at 3:01 PM
Journal of Clinical Investigation. Our results help increase the understanding of what causes severe COVID-19 and is an important piece of the puzzle in understanding the connection between the early, innate immune system, which includes M-MDSC, and the later, adaptive immune system, which includes T cells, said researcher Anna Smed Sorensen from Karolinska Institutet.
T cells are part of the immune system and play an important part in the body s protection against viral infections such as COVID-19. M-MDSCs have been shown to increase in other inflammatory conditions, and their suppressive effect on T cell activity has been established.
New Blood Test Predicts COVID-9 Recovery by Karishma Abhishek on January 17, 2021 at 6:27 PM
Developing sudden failure of organs that leads to various complications like respiratory or kidney inefficiency or requiring other intensive care remains one of the challenging aspects of COVID-19 that may cause death even in young patients.
With an aim to explore which hospitalized patients can get into such complications, involving nearly 100 patients newly admitted to the hospital with COVID-19, a simple and rapid blood test has been formulated by scientists at Washington University School of Medicine in St. Louis.
Within a day of a hospital admission, this blood test can predict the risk of patients with COVID-19 who are highly prone to develop severe complications or death, published in the journal JCI Insight.
Enzyme Blocks The Formation Of New Blood Vessels in Cancer by Pooja Shete on December 24, 2020 at 10:04 PM
Almost all the living things require oxygen to grow including cancerous tumors. A feature of the tumors is that it can develop new blood vessels (angiogenesis) if they do not get enough oxygen in order to survive.
The research conducted by Xiang-Lei Yang, PhD, a professor In the Department of Molecular Medicine at Scripps Research is published in the journal
PLOS Biology.
The study points to the exact molecular machinery that leads to angiogenesis providing scientific insights that can help develop drugs to kill tumors and stop their spread in the body.